Product correctly added to cart.

discount label
N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide
View 3D

Biosynth logo

N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide

CAS: 2097938-64-0

Ref. 3D-XID93864

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Friday 12 Jul 2024

Product Information

Name:
N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide
Description:

Gemcitabine is a cytotoxic drug that inhibits cell growth by binding to the ribonucleotide reductase enzyme, which prevents synthesis of DNA. It has minimal toxicity and can be used in a model system to study apoptosis. Gemcitabine has been shown to inhibit the production of tumor necrosis factor-α (TNF-α) and serum enzymes, such as dismutase activity, in mice with lung cancer. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. Gemcitabine is an inhibitor of the chk1 kinase and has been shown to inhibit polymerase chain reaction (PCR). This drug also binds to α1-acid glycoprotein and causes damage that leads to polymerization.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
377.3 g/mol
Formula:
C17H21BrN4O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-XID93864 N-[4-(3-Aminopiperidin-1-yl)-5-bromo-1H-indol-3-yl]cyclopropanecarboxamide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".